ATE332920T1 - Nukleinsäureimpfstoff bestehend aus einem fusionsprotein, dass eine adjuvanssequenz von einem planzenvirushüllprotein aufweist - Google Patents

Nukleinsäureimpfstoff bestehend aus einem fusionsprotein, dass eine adjuvanssequenz von einem planzenvirushüllprotein aufweist

Info

Publication number
ATE332920T1
ATE332920T1 AT01996550T AT01996550T ATE332920T1 AT E332920 T1 ATE332920 T1 AT E332920T1 AT 01996550 T AT01996550 T AT 01996550T AT 01996550 T AT01996550 T AT 01996550T AT E332920 T1 ATE332920 T1 AT E332920T1
Authority
AT
Austria
Prior art keywords
fusion protein
nucleic acid
protein
plant virus
virus envelope
Prior art date
Application number
AT01996550T
Other languages
English (en)
Inventor
Natalia Savelyeva
Freda Stevenson
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Application granted granted Critical
Publication of ATE332920T1 publication Critical patent/ATE332920T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01996550T 2000-11-20 2001-11-20 Nukleinsäureimpfstoff bestehend aus einem fusionsprotein, dass eine adjuvanssequenz von einem planzenvirushüllprotein aufweist ATE332920T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0028319.2A GB0028319D0 (en) 2000-11-20 2000-11-20 Materials and methods relating to fusion proteins for inducing an immune response

Publications (1)

Publication Number Publication Date
ATE332920T1 true ATE332920T1 (de) 2006-08-15

Family

ID=9903545

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01996550T ATE332920T1 (de) 2000-11-20 2001-11-20 Nukleinsäureimpfstoff bestehend aus einem fusionsprotein, dass eine adjuvanssequenz von einem planzenvirushüllprotein aufweist

Country Status (10)

Country Link
US (2) US7179471B2 (de)
EP (1) EP1337553B1 (de)
AT (1) ATE332920T1 (de)
AU (1) AU2002223860A1 (de)
DE (1) DE60121462T2 (de)
DK (1) DK1337553T3 (de)
ES (1) ES2267863T3 (de)
GB (1) GB0028319D0 (de)
PT (1) PT1337553E (de)
WO (1) WO2002040513A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028319D0 (en) * 2000-11-20 2001-01-03 Univ Southampton Materials and methods relating to fusion proteins for inducing an immune response
ES2431963T3 (es) * 2002-07-05 2013-11-28 Folia Biotech Inc. Partícula viral adyuvante
US20140234359A1 (en) * 2011-09-21 2014-08-21 Viral Genetics, Inc. Plant viral vaccines and therapeutics
CN111544585B (zh) * 2019-02-11 2024-12-27 北京卡替医疗技术有限公司 一种可助推免疫细胞在体内扩增的佐剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015587A1 (en) 1990-04-06 1991-10-17 Commonwealth Scientific And Industrial Research Organisation Self-polymerising expression system based on modified potyvirus coat proteins
IT1317046B1 (it) 2000-06-16 2003-05-26 Ist Superiore Sanita Proteina di fusione, particelle virali chimeriche che la espongono sulcapside, piante infettate con tali particelle, loro usi e composizioni
GB0028319D0 (en) * 2000-11-20 2001-01-03 Univ Southampton Materials and methods relating to fusion proteins for inducing an immune response

Also Published As

Publication number Publication date
GB0028319D0 (en) 2001-01-03
PT1337553E (pt) 2006-12-29
US20040072781A1 (en) 2004-04-15
AU2002223860A1 (en) 2002-05-27
WO2002040513A9 (en) 2003-05-01
DE60121462T2 (de) 2007-02-08
US7410643B2 (en) 2008-08-12
WO2002040513A3 (en) 2002-11-07
WO2002040513A2 (en) 2002-05-23
US7179471B2 (en) 2007-02-20
US20070128220A1 (en) 2007-06-07
EP1337553B1 (de) 2006-07-12
ES2267863T3 (es) 2007-03-16
DE60121462D1 (de) 2006-08-24
DK1337553T3 (da) 2006-11-13
EP1337553A2 (de) 2003-08-27

Similar Documents

Publication Publication Date Title
Plotkin Vaccines: the fourth century
RU2008106445A (ru) Вирусоподобные корпускулы (частицы) в качестве противопарамиксовирусной вакцины
DE60044665D1 (de) Her2/neu fusionsproteine
RU2003118436A (ru) Модифицированный вариант вируса коровьей оспы ankara
MXPA05009289A (es) Conjugados de particulas tipo virus del analogo del peptido melan-a.
ES2129386T1 (es) Vacuna contra influenza.
WO2002022686A3 (en) Defensin-antigen fusion proteins
UY25146A1 (es) Proteínas de fusión hpv comprendiendo una proteína e6, e7 o e6e7 fusionada con una proteína d de haemophilus influenzae b o derivados de la misma y composiciones para uso como vacunas que las comprenden
WO2002034205A3 (en) Using heat shock proteins to increase immune response
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
EP1255554A4 (de) Impfstoff spezifisch gegen nierentumore, gerichtet gegen das antigen g-250 des nierentumors
DK1441764T3 (da) Antigen-Arrays der omfatter RANKL til behandling af knoglesygdom
Francis Peptide vaccines for viral diseases
Vane et al. Genetic engineering and pharmaceuticals
CN109536529A (zh) 一种高效重组痘苗病毒载体及其建立方法
ATE332920T1 (de) Nukleinsäureimpfstoff bestehend aus einem fusionsprotein, dass eine adjuvanssequenz von einem planzenvirushüllprotein aufweist
Osorio et al. Immune responses to hepatitis B surface antigen following epidermal powder immunization
WO2002022687A3 (en) Viral chemokine-tumur antigen fusion proteins
ATE427119T1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
DE3889581D1 (de) Monoklonale Antikörper gegen spezifische antigene Regionen des humanen Immundefizienzvirus und Methoden zur Verwendung.
Barnes Strategies for an AIDS Vaccine: In their attempts to develop a vaccine against AIDS, many scientists focus on raising antibodies to a protein from the AIDS virus, a strategy that some researchers think may require modification
WO2003025002A3 (en) Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection
Kumari et al. COVID-19 Vaccines: A possible solution to ongoing pandemic
WO2002000250A3 (en) Hiv-1 vaccines and screening methods therefor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1337553

Country of ref document: EP

REN Ceased due to non-payment of the annual fee